SOX9 and pancreatic intraductal papillary-mucinous neoplasm: Simultaneous SOX9 overexpression does not affect IPMN incidence, but reduces PDAC formation, demonstrating that Sox9 is a major downstream target of Arid1a and prevents tumor progression by promoting ductal differentiation (Kimura et al., 2018).